KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,593 | -6.0% | 40,741 | +138.5% | 0.01% | -36.8% |
| Q4 2022 | $58,079 | +81.5% | 17,082 | +188.8% | 0.02% | +18.8% |
| Q3 2022 | $32,000 | -33.3% | 5,914 | -44.2% | 0.02% | -46.7% |
| Q2 2022 | $48,000 | -56.8% | 10,606 | -29.8% | 0.03% | -46.4% |
| Q1 2022 | $111,000 | +19.4% | 15,116 | +4.8% | 0.06% | +30.2% |
| Q4 2021 | $93,000 | +17.7% | 14,427 | +6.9% | 0.04% | -15.7% |
| Q3 2021 | $79,000 | -47.0% | 13,502 | -6.3% | 0.05% | -45.7% |
| Q2 2021 | $149,000 | – | 14,403 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |